Low Medicare Part D Enrollment Could Cause Sponsors To “Retrench” – Attorney
This article was originally published in The Pink Sheet Daily
Executive Summary
Slow enrollment could result in “significant consolidation” within 18 to 24 months, Sonnenschein Nath & Rosenthal partner Fried says during Drug & Device Dialogue audio conference. He also suggests that the large number of applicants seeking to sponsor Part D plans resulted from a defensive business stance by potential sponsors.
You may also be interested in...
Medicare Rx Plan Numbers Will Not Match Card Sponsor Totals, CMS’ McClellan Predicts
Seniors will not be overwhelmed by a high number of plan choices, the agency administrator maintains. CMS has received a large volume of Part D applications, but not all look “complete and serious,” McClellan indicates.
Barr’s Expanded Thalidomide ANDA Could Increase Likelihood Of A Marketed Generic
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.
User Fee Deal For Ad Review Funds Stems From PhRMA DTC Principles
A draft agreement between industry and FDA that would assess user fees for "advisory review" of broadcast direct-to-consumer ads prior to initial public dissemination had its genesis in the Pharmaceutical Research & Manufacturers of America's DTC guiding principles